Literature DB >> 33638217

Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Dawei Song1, William J Jusko1.   

Abstract

The pharmacokinetic (PK) parameters of dexamethasone (DEX) in 11 species were collected from the literature and clearances (CL) assessed by basic allometric methods, and concentration-time course profiles were fitted using two PK models incorporating physiological or allometric scaling. Plots of log CL vs. log body weights (BW) correlated reasonably with R2  = 0.91, with a maximum ratio of actual to fitted CL of 6 (for pig). A minimal physiologically-based pharmacokinetic (mPBPK) model containing blood and two lumped tissue compartments and integrated utilization of physiological parameters was compared to an allometric two-compartment model (a2CM). The plasma PK profiles of DEX from 11 species were analyzed jointly, with the mPBPK model having conserved partition coefficients (Kp ), physiologic blood and tissue volumes, and species-specific CL values. The DEX PK profiles were reasonably captured by the mPBPK model for 9 of 11 species in the joint analysis with three fitted parameters (besides CL) including an overall tissue-to-plasma partition coefficient of 1.07. The a2CM with distribution CL and central and peripheral volumes scaled allometrically fitted the plasma concentration profiles similarly but required a total of six parameters (besides CL). Overall, the literature reported that DEX CL values exhibit moderate variability (mean = 0.64 L/h/kg; coefficient of variation = 105%), but distribution parameters were largely conserved across most species.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  clearance; dexamethasone; interspecies scaling; physiological pharmacokinetics

Mesh:

Substances:

Year:  2021        PMID: 33638217      PMCID: PMC8859844          DOI: 10.1002/bdd.2266

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  71 in total

1.  Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP).

Authors:  G Hochhaus; J Barth; S al-Fayoumi; S Suarez; H Derendorf; R Hochhaus; H Möllmann
Journal:  J Clin Pharmacol       Date:  2001-04       Impact factor: 3.126

2.  A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.

Authors:  Liang Li; Zai-quan Li; Chen-hui Deng; Miao-ran Ning; Han-qing Li; Shan-shan Bi; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

3.  Comparative studies on anti-inflammatory effect and biological fates of 21-phosphates and -sulfates of dexamethasone and prednisolone.

Authors:  H Kitagawa; T Mori; M Kitagawa
Journal:  Arzneimittelforschung       Date:  1972-02

4.  Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.

Authors:  H Boxenbaum; J B Fertig
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

5.  Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in broiler chickens.

Authors:  Anneleen Watteyn; Heidi Wyns; Elke Plessers; Elisa Russo; Siegrid De Baere; Patrick De Backer; Siska Croubels
Journal:  Vet J       Date:  2012-07-24       Impact factor: 2.688

6.  A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man.

Authors:  S Miyabo; T Nakamura; S Kuwazima; S Kishida
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient rats.

Authors:  D R Varma; S Mulay
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

8.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

9.  Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland.

Authors:  P L Toutain; R A Brandon; H de Pomyers; M Alvinerie; J D Baggot
Journal:  Am J Vet Res       Date:  1984-09       Impact factor: 1.156

10.  Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women.

Authors:  Wojciech Krzyzanski; Mark A Milad; Alan H Jobe; Thomas Peppard; Robert R Bies; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-01-03       Impact factor: 2.745

View more
  3 in total

1.  Dexamethasone Transiently Enhances Transgene Expression in the Liver When Administered at Late-Phase Post Long-Term Adeno-Associated Virus Transduction.

Authors:  Zheng Chai; Xintao Zhang; Amanda Lee Dobbins; Richard Jude Samulski; Elizabeth P Merricks; Timothy C Nichols; Chengwen Li
Journal:  Hum Gene Ther       Date:  2022-01-06       Impact factor: 4.793

2.  Profound Effects of Dexamethasone on the Immunological State, Synthesis and Secretion Capacity of Human Testicular Peritubular Cells.

Authors:  Youli Konstantinovitch Stepanov; Jan Dominik Speidel; Carola Herrmann; Nina Schmid; Rüdiger Behr; Frank-Michael Köhn; Jan Bernd Stöckl; Ulrich Pickl; Matthias Trottmann; Thomas Fröhlich; Artur Mayerhofer; Harald Welter
Journal:  Cells       Date:  2022-10-09       Impact factor: 7.666

3.  Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.